iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions

Drug Discov Today. 2013 Oct;18(19-20):958-68. doi: 10.1016/j.drudis.2013.05.003. Epub 2013 May 17.

Abstract

The development of small molecule drugs targeting protein-protein interactions (PPI) represents a major challenge, in part owing to the misunderstanding of the PPI chemical space. To this end, we have manually collected the structures, the physicochemical and pharmacological profiles of 1650 PPI inhibitors across 13 families of PPI targets in a database named iPPI-DB. To access iPPI-DB, we propose a user-friendly web application (www.ippidb.cdithem.fr) with customizable queries and intuitive visualizing functionalities for associated properties of the compounds. This could assist scientists to design the next generation of PPI drugs. In this review, we describe iPPI-DB in the context of other low molecular weight molecule databases.

Publication types

  • Review

MeSH terms

  • Animals
  • Azocines / chemistry
  • Azocines / pharmacology*
  • Benzhydryl Compounds / chemistry
  • Benzhydryl Compounds / pharmacology*
  • Databases, Protein*
  • Drug Delivery Systems / methods*
  • Drug Discovery / methods*
  • Humans
  • Protein Interaction Mapping / methods*

Substances

  • Azocines
  • Benzhydryl Compounds
  • N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide